Transluminal angioplasty and stenting versus conservative treatment in patients with symptomatic basilar artery stenosis. Perspective for future clinical trials
2016 | journal article
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Transluminal angioplasty and stenting versus conservative treatment in patients with symptomatic basilar artery stenosis. Perspective for future clinical trials
Maier, I. L. ; Karch, A. ; Lipke, C.; Behme, D. ; Mpotsaris, A.; Kabbasch, C. & Liebig, T. et al. (2016)
Clinical Neuroradiology, pp. 1-6. DOI: https://doi.org/10.1007/s00062-016-0528-x
Documents & Media
Details
- Authors
- Maier, Ilko L. ; Karch, André ; Lipke, Christina; Behme, Daniel ; Mpotsaris, Anastasios; Kabbasch, Christoph; Liebig, Thomas; Faymonville, Andrea; Reich, Arno; Nikoubashman, Omid; Buhk, Jan-Hendrik; von Schoenfeld, Patrick; Weber, Werner; Mikolajczyk, Rafael T.; Bähr, Mathias ; Knauth, Michael ; Kallenberg, Kai ; Liman, Jan
- Abstract
- Two recent randomized controlled trials (RCT) consistently showed superiority of aggressive medical treatment versus percutaneous transluminal angioplasty and stenting (PTAS) in patients with intracranial artery stenosis. Patients with symptomatic basilar stenosis have a higher long-term risk of recurrent stroke compared to patients with anterior circulation stenosis but no study has specifically focused on the role of PTAS in this subgroup. The aim of our study was to investigate the subgroup of patients with symptomatic basilar artery stenosis to find evidence for the feasibility of a future clinical trial.
- Issue Date
- 2016
- Journal
- Clinical Neuroradiology
- eISSN
- 1869-1447
- Language
- English
